Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique

British Journal of Haematology

Volumn 162, Issue 4, 2013, Pages 489-497

  Darmon, Michael ^a,b   Vincent, François ^c   Camous, Laurent ^d,e,f   Canet, Emmanuel ^g,h   Bonmati, Caroline ⁱ   Braun, Thorsten ^c,j   Caillot, Denis ^k   Cornillon, Jérôme ^l   Dimicoli, Sophie ^m   Etienne, Anne ⁿ   Galicier, Lionel ^g   Garnier, Alice ^o   Girault, Stéphane ^p   Hunault Berger, Mathilde ^q   Marolleau, Jean Pierre ^r   Moreau, Philippe ^s   Raffoux, Emmanuel ^g   Recher, Christian ^t   Thiebaud, Anne ^u   Thieblemont, Catherine ^g,h   Azoulay, Elie ^g,h   more..

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b UNIVERSITÉ JEAN MONNET   (France)

^c AVICENNE HOSPITAL   (France)

^d BICÊTRE HOSPITAL   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g SAINT LOUIS HOSPITAL   (France)

^h UNIVERSITÉ PARIS DESCARTES   (France)

ⁱ UNIVERSITY HOSPITAL OF NANCY   (France)

^j UNIVERSITÉ PARIS 13   (France)

^k DIJON UNIVERSITY HOSPITAL   (France)

^l Lucien Neuwirth Oncology Institute   (France)

^m HÔTEL DIEU   (France)

ⁿ INSTITUT PAOLI CALMETTES   (France)

^o PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^p LIMOGES UNIVERSITY HOSPITAL   (France)

^q ANGERS UNIVERSITY HOSPITAL   (France)

^r AMIENS UNIVERSITY HOSPITAL   (France)

^s NANTES UNIVERSITY HOSPITAL   (France)

^t CHU PURPAN   (France)

^u GRENOBLE UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Acute kidney failure; Haematologic malignancy; Haemodialysis; Hyperphosphataemia; Intensive care units

Indexed keywords

ALLOPURINOL; ANTHRACYCLINE; BICARBONATE; CYCLOPHOSPHAMIDE; CYTARABINE; DIURETIC AGENT; LACTATE DEHYDROGENASE; PREDNISOLONE; RASBURICASE; RITUXIMAB; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE KIDNEY FAILURE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REHYDRATION; RISK FACTOR; TUMOR LYSIS SYNDROME;

ACUTE KIDNEY FAILURE; HAEMATOLOGIC MALIGNANCY; HAEMODIALYSIS; HYPERPHOSPHATAEMIA; INTENSIVE CARE UNITS;

ACUTE KIDNEY INJURY; ADULT; AGED; ALLOPURINOL; BICARBONATES; BIOLOGICAL MARKERS; COMORBIDITY; DISEASE-FREE SURVIVAL; DRUG THERAPY, COMBINATION; FEMALE; FLUID THERAPY; HEMATOLOGIC NEOPLASMS; HUMANS; HYPERPHOSPHATEMIA; MALE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REMISSION INDUCTION; RENAL REPLACEMENT THERAPY; RISK FACTORS; TUMOR BURDEN; TUMOR LYSIS SYNDROME; URATE OXIDASE;

EID: 84880703193     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12415     Document Type: Article

References (33)

1. Annemans, L., Moeremans, K., Lamotte, M., Garcia Conde, J., van den Berg, H., Myint, H., Pieters, R. & Uyttebroeck, A. (2003) Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patients. Supportive Care in Cancer, 11, 249-257.
2. Bellomo, R., Ronco, C., Kellum, J.A., Mehta, R.L. & Palevsky, P. (2004) Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care (London, England), 8, R204-R212.
3. Boles, J.M., Dutel, J.L., Briere, J., Mialon, P., Robasckiewicz, M., Garre, M. & Briere, J. (1984) Acute renal failure caused by extreme hyperphosphatemia after chemotherapy of an acute lymphoblastic leukemia. Cancer, 53, 2425-2429.
4. Cairo, M.S. & Bishop, M. (2004) Tumour lysis syndrome: new therapeutic strategies and classification. British Journal of Haematology, 127, 3-11.
5. Campara, M., Shord, S.S. & Haaf, C.M. (2009) Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach. Journal of Clinical Pharmacy and Therapeutics, 34, 207-213.
6. Chertow, G.M., Burdick, E., Honour, M., Bonventre, J.V. & Bates, D.W. (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. Journal of the American Society of Nephrology, 16, 3365-3370.
7. Cohen, L.F., Balow, J.E., Magrath, I.T., Poplack, D.G. & Ziegler, J.L. (1980) Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. The American Journal of Medicine, 68, 486-491.
8. Coiffier, B., Mounier, N., Bologna, S., Fermé, C., Tilly, H., Sonet, A., Christian, B., Casasnovas, O., Jourdan, E., Belhadj, K. & Herbrecht, R. (2003) Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study. Journal of Clinical Oncology, 21, 4402-4406.
9. Coiffier, B., Altman, A., Pui, C.-H., Younes, A. & Cairo, M.S. (2008) Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. Journal of Clinical Oncology, 26, 2767-2778.
10. Darmon, M., Thiery, G., Ciroldi, M., Porcher, R., Schlemmer, B. & Azoulay, E. (2007) Should dialysis be offered to cancer patients with acute kidney injury? Intensive Care Medicine, 33, 765-772.
11. Darmon, M., Guichard, I., Vincent, F., Schlemmer, B. & Azoulay, E. (2010) Prognostic significance of acute renal injury in acute tumor lysis syndrome. Leukemia & Lymphoma, 51, 221-227.
12. Davidson, M.B., Thakkar, S., Hix, J.K., Bhandarkar, N.D., Wong, A. & Schreiber, M.J. (2004) Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. The American Journal of Medicine, 116, 546-554.
13. Flombaum, C.D. (2000) Metabolic emergencies in the cancer patient. Seminars in Oncology, 27, 322-334.
14. Galicier, L., Fieschi, C., Borie, R., Meignin, V., Daniel, M.-T., Gérard, L. & Oksenhendler, E. (2007) Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study. Blood, 110, 2846-2854.
15. Jeha, S. (2001) Tumor lysis syndrome. Seminars in Hematology, 38, 4-8.
16. Khwaja, A. (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clinical practice, 120, 179-184.
17. Levy, E.M., Viscoli, C.M. & Horwitz, R.I. (1996) The effect of acute renal failure on mortality. A cohort analysis. JAMA, 275, 1489-1494.
18. Li, X., Hassoun, H.T., Santora, R. & Rabb, H. (2009) Organ crosstalk: the role of the kidney. Current Opinion in Critical Care, 15, 481-487.
19. Loef, B.G., Epema, A.H., Smilde, T.D., Henning, R.H., Ebels, T., Navis, G. & Stegeman, C.A. (2005) Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. Journal of the American Society of Nephrology, 16, 195-200.
20. Mahmoud, H.H., Leverger, G., Patte, C., Harvey, E. & Lascombes, F. (1998) Advances in the management of malignancy-associated hyperuricaemia. British Journal of Cancer, 77, 18-20.
21. Mato, A.R., Riccio, B.E., Qin, L., Heitjan, D.F., Carroll, M., Loren, A., Porter, D.L., Perl, A., Stadtmauer, E., Tsai, D., Gewirtz, A. & Luger, S.M. (2006) A predictive model for the detection of tumor lysis syndrome during AML induction therapy. Leukemia & Lymphoma, 47, 877-883.
22. Mehta, R.L., Kellum, J.A., Shah, S.V., Molitoris, B.A., Ronco, C., Warnock, D.G. & Levin, A. (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Critical Care (London, England), 11, R31.
23. Metnitz, P.G.H., Krenn, C.G., Steltzer, H., Lang, T., Ploder, J., Lenz, K., Le Gall, J.-R. & Druml, W. (2002) Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Critical Care Medicine, 30, 2051-2058.
24. Milpied, N., Deconinck, E., Gaillard, F., Delwail, V., Foussard, C., Berthou, C., Gressin, R., Lucas, V., Colombat, P. & Harousseau, J.-L. (2004) Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. The New England Journal of Medicine, 350, 1287-1295.
25. Montesinos, P., Lorenzo, I., Martín, G., Sanz, J., Pérez-Sirvent, M.L., Martínez, D., Ortí, G., Algarra, L., Martínez, J., Moscardó, F., de la Rubia, J., Jarque, I., Sanz, G. & Sanz, M.A. (2008) Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model. Haematologica, 93, 67-74.
26. Munker, R., Hill, U., Jehn, U., Kolb, H.J. & Schalhorn, A. (1998) Renal complications in acute leukemias. Haematologica, 83, 416-421.
27. Palevsky, P.M., Zhang, J.H., O'Connor, T.Z., Chertow, G.M., Crowley, S.T., Choudhury, D., Finkel, K., Kellum, J.A., Paganini, E., Schein, R.M.H., Smith, M.W., Swanson, K.M., Thompson, B.T., Vijayan, A., Watnick, S., Star, R.A. & Peduzzi, P. (2008) Intensity of renal support in critically ill patients with acute kidney injury. The New England Journal of Medicine, 359, 7-20.
28. Patte, C., Sakiroglu, C., Ansoborlo, S., Baruchel, A., Plouvier, E., Pacquement, H. & Babin-Boilletot, A. (2002) Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol. Annals of Oncology, 13, 789-795.
29. Pui, C.H. (2001) Urate oxidase in the prophylaxis or treatment of hyperuricemia: the United States experience. Seminars in Hematology, 38, 13-21.
30. Tallman, M.S., Kim, H.T., Paietta, E., Bennett, J.M., Dewald, G., Cassileth, P.A., Wiernik, P.H. & Rowe, J.M. (2004) Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group. Journal of Clinical Oncology, 22, 1276-1286.
31. Todeschini, G., Bonifacio, M., Tecchio, C., Balter, R., Carli, G., Stefani, P.M., Adami, F., Zamò, A., Dei Tos, A.P., Marino, F., Gherlinzoni, F., Marradi, P., Semenzato, G. & Pizzolo, G. (2012) Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia. American Journal of Hematology, 87, 22-25.
32. Wang, L.-Y., Shih, L.-Y., Chang, H., Jou, S.-T., Lin, K.-H., Yeh, T.-C., Lin, S.-F. & Liang, D.-C. (2006) Recombinant urate oxidase (rasburicase) for the prevention and treatment of tumor lysis syndrome in patients with hematologic malignancies. Acta Haematologica, 115, 35-38.
33. Závada, J., Hoste, E., Cartin-Ceba, R., Calzavacca, P., Gajic, O., Clermont, G., Bellomo, R. & Kellum, J.A. (2010) A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrology, Dialysis, Transplantation, 25, 3911-3918.